Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1100220170160040114
Dementia and Neurocognitive Disorders
2017 Volume.16 No. 4 p.114 ~ p.120
Cerebrospinal Biomarker Cut-off Methods Defined Only by Alzheimer¡¯s Disease Predict More Precisely Conversions of Mild Cognitive Impairment
Kim Jong-Hun

Lim Hyun-Sun
Lee Jee-Un
Cho Jeong-Hee
Kim Gyu-Sik
Choi Seong-Hye
Lee Jun-Hong
Abstract
Background and Purpose: The cerebrospinal fluid (CSF) biomarkers play an important supportive role as diagnostic and predictive indicators of Alzheimer¡¯s disease (AD). About 30% of controls in old age show abnormal values of CSF biomarkers and display a higher risk for AD compared with those showing normal values. The cut-off values are determined by their diagnostic accuracy. However, the current cut-off values may be less accurate, because controls include high-risk groups of AD. We sought to develop models of patients with AD, who are homogenous for CSF biomarkers.

Methods: We included participants who had CSF biomarker data in the Alzheimer¡¯s Disease Neuroimaging Initiative database. We investigated the factors related to CSF biomarkers in patients with AD using linear mixed models. Using the factors, we developed models corresponding to CSF biomarkers to classify patients with mild cognitive impairment (MCI) into high risk and low risk and analyzed the conversion from MCI to AD using the Cox proportional hazards model.

Results: APOE ¥å4 status and age were significantly related to CSF A¥â1-42. CSF t-tau, APOE ¥å2 status and sex were significant factors. The CSF p-tau181 was associated with age and frequency of diagnosis. Accordingly, we modeled the three CSF biomarkers of AD. In MCI without APOE ¥å4, our models were better predictors of conversion.

Conclusions: We can interpret CSF biomarkers based on the models derived from the data obtained from patients with AD.
KEYWORD
Alzheimer¡¯s disease, cerebrospinal fluid biomarker, mild cognitive impairment, diagnosis, prediction, conversion
FullTexts / Linksout information
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed